Superior graft-vs-leukemia effects after transplantation of murine allogeneic peripheral blood progenitor cells (PBPC) as compared to bone marrow.

被引:0
作者
Zeis, M
Uharek, L
Glass, B
Steinmann, J
Dreger, P
Schmitz, N
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT INTERNAL MED 2,D-2300 KIEL,GERMANY
[2] CHRISTIAN ALBRECHTS UNIV KIEL,INST IMMUNOL,D-2300 KIEL,GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:970 / 970
页数:1
相关论文
共 50 条
  • [41] Superior graft-versus-leukemia activity after transplantation of peripheral blood progenitor cell (PBPC) grafts mobilized by g-CSF and SCF compared to g-CSF alone.
    Uharek, L
    Hartung, G
    Zeis, M
    Glass, B
    Schmitz, N
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 207 - 207
  • [42] Immunotherapy of acute leukemia relapsing after allogeneic transplantation: The inseparability of GVHD and graft-vs-leukemia, and the problem of extramedullary relapse.
    Singhal, S
    Powles, R
    Kulkarni, S
    Treleaven, J
    Mehta, J
    BONE MARROW TRANSPLANTATION, 1998, 21 : S69 - S69
  • [43] Peripheral blood precursor cells instead of bone marrow cells for allogeneic transplantation
    Gratwohl, A
    Tichelli, A
    Bargetzi, M
    Jeannet, M
    Nissen, C
    Speck, B
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 (09) : 357 - 361
  • [44] Graft vs. Host Disease incidence in patients with allogeneic peripheral blood progenitor cells transplantation.
    Milone, G
    Rolón, JM
    Fernandez, I
    Corrado, C
    Desmery, P
    Pavlovsky, S
    BLOOD, 1999, 94 (10) : 370B - 370B
  • [45] Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes
    Slavin, S
    Naparstek, E
    Nagler, A
    Ackerstein, A
    Kapelushnik, J
    Or, R
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (14) : 1553 - 1562
  • [46] Clinical and economic comparison of allogeneic peripheral blood progenitor cell and bone marrow transplantation for acute lymphoblastic leukemia in children
    L Madero
    M González Vicent
    M Ramirez
    V Quintero
    A Benito
    MA Díaz
    Bone Marrow Transplantation, 2000, 26 : 269 - 273
  • [47] Cost comparative study peripheral blood progenitor cells (PBPC) and autologous bone marrow transplantation (ABMT) for lymphomas patients.
    WoronoffLemsi, MC
    Limat, S
    Deconinck, E
    Arveux, P
    Cahn, JY
    BLOOD, 1995, 86 (10) : 822 - 822
  • [48] CHARACTERIZATION OF EFFECTOR-CELLS OF GRAFT VS LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION IN MICE INOCULATED WITH MURINE B-CELL LEUKEMIA
    WEISS, L
    WEIGENSBERG, M
    MORECKI, S
    BAR, S
    COBBOLD, S
    WALDMANN, H
    SLAVIN, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990, 31 (04) : 236 - 242
  • [49] Comparison of engraftment and GVL activity after allogeneic bone marrow and peripheral blood progenitor cell transplantation (PBPCT).
    Uharek, L
    Glass, B
    Zeis, M
    Dreger, P
    Gassmann, W
    Loffler, H
    Schmitz, N
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 617 - 617
  • [50] Clinical and economic comparison of allogeneic peripheral blood progenitor cell and bone marrow transplantation for acute lymphoblastic leukemia in children
    Madero, L
    Vicent, MG
    Ramirez, M
    Quintero, V
    Benito, A
    Díaz, MA
    BONE MARROW TRANSPLANTATION, 2000, 26 (03) : 269 - 273